ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutic products to patients. Through Lilly ICOS LLC (Lilly ICOS), our joint venture with Eli Lilly and Company (Lilly), we are marketing Cialis ® (tadalafil) for the treatment of erectile dysfunction. Lilly ICOS also is evaluating tadalafil as a potential treatment in benign prostatic hyperplasia (BPH), hypertension and pulmonary arterial hypertension (PAH). ICOS also is working to develop and commercialize potential treatments for other serious unmet medical conditions such as cancer and inflammatory diseases.

Over the years, we...